• Home
• About Us
• Products
• News & Events
• Support
• Contact

CleveMed Home > CleveMed News and Events

CleveMed News Releases

For More Information Contact:

Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
Arickard@clevemed.com
www.clevemed.com

---

FOR IMMEDIATE RELEASE

AASM COMPLIANT SOFTWARE UPDATE HELPS CUT COSTS BY STREAMLINING SLEEP DIAGNOSTIC WORKFLOW

CLEVELAND, OHIO, AUGUST 6, 2008 - Cleveland Medical Devices Inc. (CleveMed) announced a major release of its sleep diagnostic software, Crystal PSG. The latest feature set includes a number of time and cost saving features that will enable doctors to diagnose patients faster. Most notably, this release includes a high-quality real-time and offline automated respiratory scoring system that dramatically improves study turnaround time. This release also includes necessary features to comply with new requirements from the American Academy of Sleep Medicine (AASM) and recommendations from our valued customers.

"Not only does our software upgrade meet the new guidelines of the American Academy of Sleep Medicine, it improves the workflow to the technologist and physician by speeding scoring, data management, archiving, and study interpretation. This upgrade further strengthens our portfolio of sleep diagnostic systems, which are designed to expand the reach of sleep medicine to new and emerging settings such as patients' homes, inpatient evaluation, and nursing homes", said Sarah Weimer, Sleep products manager.

Crystal PSG software is used with all three of CleveMed's sleep diagnostic systems. Sapphire PSG^™ and the Crystal Monitor^® PSG Series are wireless, handheld PSG systems, ideal for traditional sleep labs as well as new settings such as hospital inpatient rooms and nursing homes. The 9-channel Type III SleepScout^™ offers portable sleep monitoring for sleep apnea diagnosis in patients homes.

About CleveMed

CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders, sleep disorders and brain monitoring. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.CleveMed.com

About Obstructive Sleep Apnea (OSA)

The National Heart, Lung, and Blood Institute estimates that sleep apnea is prevalent in as many as 18 million Americans alone. Two to four percent of all Americans have an undiagnosed case of sleep apnea. OSA occurs in approximately 2 percent of women and 4 percent of men over the age of 35. Patients with OSA regularly experience fatigue and tiredness along with long periods of snoring with brief pauses during sleep. In some cases OSA is life threatening and may add to the risks of Heart attack, Stroke, High blood pressure and other health problems.